Agios’ first-ever pediatric data readout missed the primary endpoint, with its drug Pyrukynd (mitapivat) not showing statistical significance in children with pyruvate kinase (PK) deficiency …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
A popular biologic medicine used to combat autoimmune diseases cost Medicare and its beneficiaries considerably more when the injectable treatment was obtained at pharmacies rather
The FDA approved long-acting injectable somatrogon (Ngenla) for pediatric human growth hormone deficiency, developers Pfizer and OPKO Health announced this week. Somatrogon is indicated for
Study reveals improvements in cognitive deficits and fatigue among long-COVID patients over two years, with specific risk factors like depressive symptoms and old age predicting